Search Results - "Goland, R."

Refine Results
  1. 1
  2. 2

    VMAT2 quantitation by PET as a biomarker for β-cell mass in health and disease by Freeby, M, Goland, R, Ichise, M, Maffei, A, Leibel, R, Harris, P

    Published in Diabetes, obesity & metabolism (01-11-2008)
    “…The common pathology underlying both type 1 and type 2 diabetes (T1DM and T2DM) is insufficient β-cell mass (BCM) to meet metabolic demands. An important…”
    Get full text
    Journal Article
  3. 3

    Diabetes-related parameters and periodontal conditions in children by Lalla, E., Cheng, B., Lal, S., Kaplan, S., Softness, B., Greenberg, E., Goland, R. S., Lamster, I. B.

    Published in Journal of periodontal research (01-08-2007)
    “…Background and Objective:  The relationship between diabetes and periodontal diseases is well established. Our aim in this study was to explore the…”
    Get full text
    Journal Article
  4. 4

    Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses by Goland, R S, Jozak, S, Warren, W B, Conwell, I M, Stark, R I, Tropper, P J

    “…CRH is synthesized in the hypothalamus and released in response to stress into the portal hypophyseal blood; an additional site of synthesis, the placenta, is…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Stimulatory effects of stress on gonadotropin secretion in estrogen-treated women by PUDER, J. J, FREDA, P. U, GOLAND, R. S, FERIN, M, WARDLAW, S. L

    “…Although stress is known to inhibit the hypothalamic-pituitary-gonadal axis, recent studies in the monkey show that, under certain conditions, in the presence…”
    Get full text
    Journal Article
  7. 7

    Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor by Warren, W B, Patrick, S L, Goland, R S

    “…We investigated whether maternal plasma levels of the placental hormone corticotropin-releasing hormone are elevated in pregnancies complicated by preterm…”
    Get more information
    Journal Article
  8. 8

    Placental corticotropin-releasing hormone and the hypercortisolism of pregnancy by Goland, Robin S., Jozak, Sheila, Conwell, Irene

    “…Objective: Our purpose was to clarify whether placental corticotropin-releasing hormone regulates pituitary-adrenal function in human pregnancy. Study Design:…”
    Get full text
    Journal Article
  9. 9

    Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women by Puder, J J, Freda, P U, Goland, R S, Wardlaw, S L

    “…Endotoxin stimulates the release of the inflammatory cytokines interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-alpha, which are potent activators of…”
    Get full text
    Journal Article
  10. 10

    The effect of pre-eclampsia on human placental corticotrophin-releasing hormone content and processing by Goland, R.S., Conwell, I.M., Jozak, S.

    Published in Placenta (Eastbourne) (01-06-1995)
    “…Prior studies have shown that levels of corticotrophin-releasing hormone (CRH) in the umbilical cord blood of infants born after pregnancies complicated by…”
    Get full text
    Journal Article
  11. 11

    High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy by Goland, R S, Wardlaw, S L, Stark, R I, Brown, Jr, L S, Frantz, A G

    “…Corticotropin-releasing hormone immunoactivity (CRHi) was measured in the plasma of 31 pregnant women and 6 nonpregnant women as well as in the umbilical cord…”
    Get more information
    Journal Article
  12. 12

    A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes by Zeitler, Phil, Hirst, Kathryn, Pyle, Laura, Linder, Barbara, Copeland, Kenneth, Arslanian, Silva, Cuttler, Leona, Nathan, David M, Tollefsen, Sherida, Wilfley, Denise, Kaufman, Francine

    Published in The New England journal of medicine (14-06-2012)
    “…In this study of treatments for recent-onset type 2 diabetes, metformin monotherapy was associated with durable glycemic control in about 50% of patients. The…”
    Get full text
    Journal Article
  13. 13

    Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes by Haller, Michael J., Schatz, Desmond A., Skyler, Jay S., Krischer, Jeffrey P., Bundy, Brian N., Miller, Jessica L., Atkinson, Mark A., Becker, Dorothy J., Baidal, David, DiMeglio, Linda A., Gitelman, Stephen E., Goland, Robin, Gottlieb, Peter A., Herold, Kevan C., Marks, Jennifer B., Moran, Antoinette, Rodriguez, Henry, Russell, William, Wilson, Darrell M., Greenbaum, Carla J., Greenbaum, C., Atkinson, M., Baidal, D., Battaglia, M., Becker, D., Bingley, P., Bosi, E., Buckner, J., Clements, M., Colman, P., DiMeglio, L., Evans-Molina, C., Gitelman, S., Goland, R., Gottlieb, P., Herold, K., Knip, M., Krischer, J., Lernmark, A., Moore, W., Moran, A., Muir, A., Palmer, J., Peakman, M., Philipson, L., Raskin, P., Redondo, M., Rodriguez, H., Russell, W., Spain, L., Schatz, D.A., Sosenko, J., Wherrett, D., Wilson, D., Winter, W., Ziegler, A., Anderson, M., Antinozzi, P., Benoist, C., Blum, J., Bourcier, K., Chase, P., Clare-Salzler, M., Clynes, R., Cowie, C., Eisenbarth, G., Fathman, C.G., Grave, G., Harrison, L., Hering, B., Insel, R., Jordan, S., Kaufman, F., Kay, T., Kenyon, N., Klines, R., Lachin, J., Leschek, E., Mahon, J., Marks, J.B., Monzavi, R., Nanto-Salonen, K., Nepom, G., Orban, T., Parkman, R., Pescovitz, M., Peyman, J., Pugliese, A., Ridge, J., Roep, B., Roncarolo, M., Savage, P., Simell, O., Sherwin, R., Siegelman, M., Skyler, J.S., Steck, A., Thomas, J., Trucco, M., Wagner, J.

    Published in Diabetes care (01-09-2018)
    “…OBJECTIVE A pilot study suggested that combination therapy with low-dose anti-thymocyte globulin (ATG) and pegylated granulocyte colony-stimulating factor…”
    Get full text
    Journal Article
  14. 14

    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial by Krischer, Jeffrey P, Schatz, Desmond A, Bundy, Brian, Skyler, Jay S, Greenbaum, Carla J

    “…IMPORTANCE: Type 1 diabetes requires major lifestyle changes and carries increased morbidity and mortality. Prevention or delay of diabetes would have major…”
    Get full text
    Journal Article
  15. 15

    Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy by Goland, R S, Wardlaw, S L, Blum, M, Tropper, P J, Stark, R I

    “…Corticotropin-releasing hormone was measured in the plasma of 110 pregnant women and in the umbilical cord plasma of 25 premature infants and 43 infants born…”
    Get more information
    Journal Article
  16. 16

    Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia by Goland, R S, Tropper, P J, Warren, W B, Stark, R I, Jozak, S M, Conwell, I M

    “…The effect of pre-eclampsia on concentrations of corticotrophin releasing hormone (CRH) in umbilical-cord blood of fetuses at delivery was studied in order to…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension by Warren, Wendy B., Gurewitsch, Edith D., Goland, Robin S.

    “…OBJECTIVE: We hypothesized that maternal plasma corticotropin-releasing hormone levels are elevated in chronic hypertension and that elevations modulate…”
    Get full text
    Journal Article
  19. 19
  20. 20